Abstract:
The description provides novel compounds that may serve as anticancer therapeutics. The compounds of the description bind to polo-like kinases through the polo-box domain. The peptide derivatives of the description have achieved improved efficacy in biochemical assays against Plk1. The description also provides methods of use, methods of preparation, compositions, and kits thereof. Further, the description provides a novel method of design and/or synthesis of phosphoryl-derived peptide derivatives useful as therapeutic agents.
Abstract:
Compounds of the form in which Q is selected from -COOH -CH=NR 12 , -W, -CH 2 NHR 13 , -CH=0 and -CH(OR 17 ) 2 capable of modulating the activity of histone demethylases (HDMEs), which are useful for prevention and/or treatment of diseases in which genomic dysregulation is involved in the pathogenesis, such as e.g. cancer and formulations and methods of use of such compounds.
Abstract:
The present invention provides a process for the preparation of key intermediate for the synthesis 5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1-indanone hydrochloride (donepezil hydrochloride). The present invention particularly provides a process for the preparation of 5,6-dimethoxy-2-(4-pyridylmethylene)-1-indanone comprising condensation of 5,6-dimethoxy-1-indanone with 4- pyridinecarboxaldehyde using an alkali metal hydroxide as a mild base in the presence of demineralized water as a solvent at a temperature in the range of 15°C to 45°C to yield 5,6-dimethoxy-2-(4-pyridylmethylene)-1-indanone, which is subsequently benzylated using benzyl bromide in the presence of solvent at a reflux temperature to yield 1-benzyl-4-[(5,6-dimethoxy-1-indanone-2-yl)methylene]pyridinium bromide.
Abstract:
Die vorliegende Erfindung beschreibt neue beta-Aminoaldehyd-Derivate der Formeln (I), (II) und (III),in welchen die Substituenten R 1 bis R 5 und A die in der Beschreibung angegebene Bedeutung haben, ein neues Verfahren zur deren Herstellung, dessen Zwischenprodukte, sowie Verwendungen dieser neuen beta-Aminoaldehyd-Derivate, z.B. zur (chemischen) Verwendung als reaktive Intermediate, zur Verwendung in der Medizin, z.B. als Peptidomimetikum, als Kopplungsagens, etc.
Abstract:
Die vorliegende Erfindung beschreibt ein Verfahren zur Herstellung von Aldehyden und Ketonenaus günstig zugänglichen primären und sekundären Alkoholen durch Oxidation mit Luftsauerstoff oder reinem Sauerstoff mittels eines Katalysatorsystems bestehend aus einem freien Nitroxylradikalderivat.
Abstract:
The invention provides compounds of formula (I) or pharmaceutically acceptable salts thereof, (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Z, X and B are as defined in the specification. The compounds are partial or full agonists at the GPR38 receptor. Pharmaceutical compositions comprising the compounds, methods of preparing the compounds, uses of the compounds and methods involving the compounds are also provided.
Abstract:
The present invention relates to the use of an Ih channel modulator in the manufacture of a medicament for use in psychiatry. To certain novel methanamine derivatives, to processes for their preparation, to pharmaceutical formulations containing them and to their use in medical therapy, particularly for use in psychiatry.
Abstract:
The present disclosure relates to compounds of the general formula (I) and pharmaceutical compositions containing them. The compounds are suitable as modulators of hemoglobin and thus useful in treating disorders mediated by hemoglobin such as sickle cell disease.